Capital Advisory Group Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,003
Closed -$111K 362
2022
Q1
$111K Buy
+1,003
New +$106K 0.05% 191
2021
Q4
Sell
-320
Closed -$40K 354
2021
Q3
$40K Sell
320
-44
-12% -$5.7K 0.01% 277
2021
Q2
$45K Hold
364
0.02% 275
2021
Q1
$43K Hold
364
0.02% 257
2020
Q4
$43K Buy
364
+17
+5% +$1.87K 0.02% 258
2020
Q3
$36K Sell
347
-32
-8% -$3.21K 0.02% 221
2020
Q2
$35K Sell
379
-500
-57% -$47.9K 0.02% 212
2020
Q1
$79K Buy
+879
New +$93.5K 0.1% 98
2019
Q4
Sell
-820
Closed -$89K 324
2019
Q3
$89K Hold
820
0.06% 125
2019
Q2
$81K Hold
820
0.05% 126
2019
Q1
$75K Hold
820
0.05% 122
2018
Q4
$74K Hold
820
0.06% 117
2018
Q3
$81K Hold
820
0.05% 116
2018
Q2
$72K Hold
820
0.05% 115
2018
Q1
$66K Buy
+820
New +$67.6K 0.05% 120

Other funds holding MDT

Capital Advisory Group Advisory Services's MDT Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,003 shares — an estimated $111K sold.

Capital Advisory Group Advisory Services first reported a position in MDT in Q1 2018 and held it in 15 quarters. The position peaked at $111K in Q1 2022. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Capital Advisory Group Advisory Services reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 1,003 Medtronic shares in Q2 2022, an estimated $111K.
  • Capital Advisory Group Advisory Services first reported a position in Medtronic in Q1 2018 and held it in 15 quarters.
  • Capital Advisory Group Advisory Services's Medtronic position peaked at $111K in Q1 2022.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.